Date of birth: unknown.
Date of event: unknown.
The date received by manufacturer has been used for this field.
The initial reporter also notified the fda on 3 august, 2020.
Medwatch report # (b)(4) report source other: medwatch report.
A device evaluation and/or device history review is anticipated, but is not complete.
Upon completion, a supplemental report will be filed.
(b)(4).
|
It was reported that 25gx3.
5in whit 5ml glaspak bupi clear anesthesia was ineffective.
This was discovered during use.
The following information was provided by the initial reporter: material no: 400866 batch no: 0001311129.
It was reported that the anesthesia was ineffective which required the procedure to be completed using general anesthesia.
Event description per email states: 0630.
Scheduled repeat cesarean section.
Easy spinal, 1st attempt by crna.
Free flowing cerebrospinal fluid (csf) drops and swirl in syringe ¿ 1.
6ml of kit 0.
75% bupivacaine + 10mcg fentanyl + 200mcg duramorph injected.
Foley insertion tolerated, patient able to move legs and differentiate cold, touch, sharp.
Lot # of spinal kit ¿ 0001311129.
Patient had to have general anesthesia due to failed spinal.
Notes from the operative report.
¿the patient was taken to the operating room where spinal anesthesia was performed, seemingly without complication, but was noted to be not effective at this point.
Anesthesia determined she would require general anesthesia.
General anesthesia was initiated without complication.
|